HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 23, No 11, November 2019 – Evaluating cost effectiveness of genomic profiling       » Ion treatment offers new hope for cancer patients       » Empowering sustainability through innovation       » Meeting clinical needs in Asia with HealthTech       » The key in diagnosis and treatment       » Singapore's first private co-working laboratory and office space       » Singapore-based MedTech company announced as winner of 2019 Asia Pacific Showcase Competition at The MedTech Forum      
ASIA-PACIFIC
Exosomes found to aid in fighting Dengue infection
New area for exosome research shows potential therapeutic strategy for treating Dengue Fever.

Despite intensive research, there has been no effective pharmaceutical treatment for Dengue fever. Personal protection measure to avoid mosquito bites and environmental management to prevent mosquito breeding remain the only available strategies to prevent transmission.

In the latest Nature Communications, Dr. Edmond Hsieh’s research team reported their newest findings in treating Dengue fever. This study not only provided a possible therapeutic strategy to treat Dengue fever, but also opened a new avenue for exosomes research field.

Dr. Hsieh’s team found that Dengue viral infection causes extensive haemorrhage and triggers immune-mediated cytokine reaction. The patient's immune system becomes out of control and difficulties in treatment. They also found that a C-Type lectin receptor (CLEC5A) on macrophages, is a key factor for Dengue infection. They further generated specific antibody to against CLEC5A and successfully increased the survival rate of Dengue infected mice from zero to 50 per cent. However, no matter how hard they modified the antibody, the effectiveness of the treatment still could not break the 50 per cent mark. Dr. Hsieh decided to investigate further, the first author of this paper, Song Pei-Shan, a Ph.D. student at Yang Ming University found that the dengue virus upon infection will cause cytokine reactions that acts through CLEC5A on macrophages and activating platelets.

In this study, the team discovered that dengue virus can activate platelets to induce release of tiny substances, called “extracellular vesicles (EVs)”, or, exosomes. Because these vesicles are so tiny, traditionally they are considered insignificant.

It turned out that exosomes secreted from platelets after dengue viral intrusion are target specific. These vesicles would turn around to target the white blood cells. The attack is precisely targeted toward CLEC5A and TLR2 on both neutrophils and macrophages. This will activate the immune system and cause a cytokine reaction stirred up by the macrophages, the platelet-secreted exosomes targeted neutrophils would release its own DNA to form Neutrophil Extracellular Traps (NETs) this can result in damage on the internal organs.

By treating the dengue viral infected mice with antibodies against CLEC5A and TLR2, the survival rate reached over 90 per cent.

Dr. Hsieh confidently said that this study found not only the critical infection pathway of dengue virus, but also unveiled a previously unknown function of EVs.

Click here for the complete issue.

NEWS CRUNCH  
news ECV2019 China Healthcare and Pharma Digital Innovation Summit Held Successfully in Shanghai — The "Highway" Era of Healthcare Digital Transformation
news Natural Extracts Innovated, Transformed and Diversely Laid Out to Embrace the Blue Ocean Market of Big Health
news The Proteona Oncology Challenge using ESCAPETM Single Cell Proteogenomic Analysis
news New computational fluid dynamics solution for modeling aerosol mixtures in biomedical and environmental research
PR NEWSWIRE  
Asia Pacific Biotech News
SPOTLIGHT  
LIFE OF A SCIENTIST  

APBN Editorial Calendar 2019
January:
Taiwan Medical tourism
February:
Marijuana as medicine — Legal marijuana will open up scientific research
March:
Driven by curiosity
April:
Career developments for researchers
May:
What's cracking — Antibodies in ostrich eggs
June:
Clinical trials — What's in a name?
July:
Traditional Chinese medicine in modern healthcare — Integrating both worlds
August:
Digitalization vs Digitization — Exploring Emerging Trends in Healthcare
September:
Healthy Ageing — How Science is chipping in
October:
Disruptive Urban Farming — Microbes, Plasmids, and Recycling
November:
Evaluating cost effectiveness of genomic profiling
Editorial calendar is subjected to changes.
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Deborah Seah
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2019 World Scientific Publishing Co Pte Ltd  •  Privacy Policy